TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21372283

Group type: EXPERIMENTAL
Intervention: 9p21 haplotype comprising the risk allele for SNPs in whites
Number of subjects: 1460

Group type: EXPERIMENTAL
Intervention: 9p21 haplotype comprising the risk allele for SNPs in blacks
Number of subjects: 1460

Group type: EXPERIMENTAL
Intervention: 9p21 haplotype comprising the risk allele for SNPs in Hispanics
Number of subjects: 1460

Group type: EXPERIMENTAL
Intervention: Less commonly reported linkage disequilibrium block in whites
Number of subjects: 1460

Group type: EXPERIMENTAL
Intervention: Less commonly reported linkage disequilibrium block in blacks
Number of subjects: 1460
Study: 19804632

Group type: EXPERIMENTAL
Intervention: Intervention program provided by trained psychologists and social workers, including counselling on work resumption and family support.
Number of subjects: 161

Group type: COMPARATOR
Intervention: Usual care (control group) with access to welfare benefits.
Number of subjects: 161
Study: 17276668

Group type: EXPERIMENTAL
Intervention: Colloid preload
Number of subjects: 55

Group type: COMPARATOR
Intervention: Crystalloid preload
Number of subjects: 55
Study: 15180765

Group type: EXPERIMENTAL
Intervention: Rupatadine 10 mg
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Ebastine 10 mg
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study: 12213858

Group type: EXPERIMENTAL
Intervention: Raloxifene (60 mg/d)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 9617706

Group type: EXPERIMENTAL
Intervention: Second-stage neuroborreliosis
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Stage II features
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Acute meningomyelitis or meningomyeloradiculitis
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Meningoencephalitis or meningenocephaloradiculitis
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Chronic course (stage III)
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Cerebrovascular neuroborreliosis
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Involvement of other organs
Number of subjects: 330
Study: 8571717

Group type: EXPERIMENTAL
Intervention: Intraperitoneal polyglactin mesh
Number of subjects: 112

Group type: COMPARATOR
Intervention: No intraperitoneal polyglactin mesh (control)
Number of subjects: 112
Study: 2488104

Group type: EXPERIMENTAL
Intervention: Controlled-release metoprolol (CR) 100 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Controlled-release metoprolol (CR) 200 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Metoprolol Durules 200 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Metoprolol plain tablet 100 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 13418

Group type: EXPERIMENTAL
Intervention: TRH administered to 6 patients with endogenous depressions
Number of subjects: 46

Group type: COMPARATOR
Intervention: TRH 1000 mug for 10 days
Number of subjects: 46

Group type: COMPARATOR
Intervention: MIF-1 60 mg per day for 6 days
Number of subjects: 46

Group type: COMPARATOR
Intervention: MIF-1 150 mg per day
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: MIF-1 75 mg per day
Number of subjects: 46

Group type: COMPARATOR
Intervention: MIF-1 750 mg per day
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: LHRH 700 mug or saline once daily for 3 consecutive days per week
Number of subjects: 46

Group type: COMPARATOR
Intervention: Higher doses of LHRH in a single-blinded study
Number of subjects: 46
Study: 31647470

Group type: EXPERIMENTAL
Intervention: 23vPPV vaccine
Number of subjects: 4725

Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 4725
Study: 29102353

Group type: EXPERIMENTAL
Intervention: Intervention group (12 hospitals)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (13 hospitals)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Intervention effect
Number of subjects: 25
Study: 26209121

Group type: EXPERIMENTAL
Intervention: Seizure First Aid Training intervention
Number of subjects: 80

Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 80
Study: 23936304

Group type: EXPERIMENTAL
Intervention: PCT guided treatment
Number of subjects: 337

Group type: COMPARATOR
Intervention: Standard care clinical guidelines
Number of subjects: 337
Study: 23672753

Group type: EXPERIMENTAL
Intervention: Laparoscopy-assisted gastrectomy (LAG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional open gastrectomy (OG)
Number of subjects: 30
Study: 19855285

Group type: EXPERIMENTAL
Intervention: Intermittent therapy (IT)
Number of subjects: 391

Group type: COMPARATOR
Intervention: Continuous therapy (CT)
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: History of thrombocytopenia
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Low baseline platelet count
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Changes from baseline in platelet counts
Number of subjects: 391
Study: 16899100

Group type: EXPERIMENTAL
Intervention: Vector ‐system with polishing (VP)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Vector ‐system with abrasive fluid (VA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional ultrasonic system (U)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Hand instruments (H)
Number of subjects: 40
Study: 14763994

Group type: EXPERIMENTAL
Intervention: Serum total testosterone levels in AD patients
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Serum free testosterone levels in AD patients
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Free androgen index (FAI) in AD patients
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: SHBG levels in AD patients
Number of subjects: 30

Group type: COMPARATOR
Intervention: FAI in cognitively normal controls
Number of subjects: 30
Study: 11280679

Group type: EXPERIMENTAL
Intervention: Selenium supplementation (500 microg Se daily for 5 days)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo (vehicle)
Number of subjects: 31
Study: 9042045

Group type: EXPERIMENTAL
Intervention: Pediatric completers
Number of subjects: 362
Study: 7943386

Group type: EXPERIMENTAL
Intervention: Tilt maneuver
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atrial pacing with constant heart rate
Number of subjects: 0
Study: 3350203

Group type: EXPERIMENTAL
Intervention: 20 mg aspirin daily
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 75 mg dipyridamole three times daily
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Combination of aspirin and dipyridamole
Number of subjects: 18
Study: 31822377

Group type: EXPERIMENTAL
Intervention: Self-management intervention for adolescent headache (SMI-AH, n = 13)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard care group (n = 17)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Self-management intervention for adolescent headache (SMI-AH)
Number of subjects: 30
Study: 30767637

Group type: EXPERIMENTAL
Intervention: Botanically-enriched topical salve (BES)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Base salve (BS)
Number of subjects: 16
Study: 28225483

Group type: EXPERIMENTAL
Intervention: tHcy quartiles (Q2, Q3, Q4)
Number of subjects: 20424

Group type: EXPERIMENTAL
Intervention: MTHFR genotype (CC/CT)
Number of subjects: 20424
Study: 25735707

Group type: EXPERIMENTAL
Intervention: rTMS
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: tDCS
Number of subjects: 90

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 90
Study: 23086750

Group type: EXPERIMENTAL
Intervention: Chlorambucil and fludarabine with cyclophosphamide
Number of subjects: 494

Group type: COMPARATOR
Intervention: Chlorambucil and fludarabine without cyclophosphamide
Number of subjects: 494
Study: 21575959

Group type: EXPERIMENTAL
Intervention: Oral tadalafil 20 mg plus low dose intracavernous injection of vasoactive agents (15 mg papaverine plus 20 mg tadalafil)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Oral tadalafil 20 mg
Number of subjects: 56

Group type: COMPARATOR
Intervention: Intracavernous injection mode (30 to 60 mg papaverine)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Patient preference
Number of subjects: 56
Study: 20015432

Group type: EXPERIMENTAL
Intervention: Kneading and dispersing manipulation
Number of subjects: 198

Group type: COMPARATOR
Intervention: Cefradine (oral administration)
Number of subjects: 198
Study: 16413010

Group type: EXPERIMENTAL
Intervention: Warfarin (mean daily dose 3.11±1.62 mg)
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: C‐65 variant carriers
Number of subjects: 239

Group type: COMPARATOR
Intervention: Healthy controls (Caucasians and African‐Americans)
Number of subjects: 239
Study: 14652518

Group type: EXPERIMENTAL
Intervention: CONFOR‐Med mattress/cushion combination
Number of subjects: 1168

Group type: COMPARATOR
Intervention: Standard mattress/cushion combination
Number of subjects: 1168
Study: 11126272

Group type: EXPERIMENTAL
Intervention: iloprost infusion (1 ng/kg per minute) for 24 h
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group not mentioned
Number of subjects: 20
Study: 9236309

Group type: EXPERIMENTAL
Intervention: Pregnancy
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Pregnancy (first 12 weeks)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Pregnancy (past 12 weeks)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Non-pregnant women
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Current pregnancy
Number of subjects: 189
Study: 1615190

Group type: EXPERIMENTAL
Intervention: Inhaled terbutaline
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 6393181

Group type: EXPERIMENTAL
Intervention: Hypnosis and cognitive coping skills
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Relaxation and cognitive coping skills
Number of subjects: 61

Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 61
Study: 30944249

Group type: EXPERIMENTAL
Intervention: High-fat diet, primarily unsaturated
Number of subjects: 9

Group type: COMPARATOR
Intervention: Low-fat, high-carbohydrate diet
Number of subjects: 9
Study: 29884657

Group type: EXPERIMENTAL
Intervention: Centralized, remote clinical pharmacy service for 12 months
Number of subjects: 302

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Centralized, remote clinical pharmacy service
Number of subjects: 302
Study: 26073190

Group type: EXPERIMENTAL
Intervention: Breakfast
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fasting (no breakfast)
Number of subjects: 20
Study: 24939352

Group type: EXPERIMENTAL
Intervention: Individual online learning
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Group online learning
Number of subjects: 15

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 15
Study: 22997781

Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 64

Group type: COMPARATOR
Intervention: Acupuncture
Number of subjects: 64
Study: 19136144

Group type: COMPARATOR
Intervention: Long-acting opioid analgesics
Number of subjects: 10
Study: 18620498

Group type: EXPERIMENTAL
Intervention: Phyllanthus niruri
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dolichos biflorus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Orthosiphon grandiflorus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fish stone
Number of subjects: 0
Study: 11693062

Group type: EXPERIMENTAL
Intervention: Interferon alpha as maintenance treatment
Number of subjects: 167

Group type: COMPARATOR
Intervention: Cyclically alternating interferon alpha and dexamethasone treatment
Number of subjects: 167
Study: 9204089

Group type: EXPERIMENTAL
Intervention: Adapalene 0.1% gel
Number of subjects: 591

Group type: COMPARATOR
Intervention: Tretinoin 0.025% gel
Number of subjects: 591
Study: 8434322

Group type: EXPERIMENTAL
Intervention: 2 mL of standard-dose chymopapain (4,000 units)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: 2 mL of low-dose chymopapain (2,000 units)
Number of subjects: 118
Study: 3304172

Group type: EXPERIMENTAL
Intervention: Creon
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pancrease
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pancrex V Forte
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pancreatin Merck
Number of subjects: 0
Study: 29485322

Group type: EXPERIMENTAL
Intervention: Colonoscopy
Number of subjects: 8844

Group type: EXPERIMENTAL
Intervention: CT Colonography
Number of subjects: 8844
Study: 28704146

Group type: EXPERIMENTAL
Intervention: Legacy Intervention (LI)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Partial Hospital Program only (PHP-only)
Number of subjects: 80
Study: 26817117

Group type: COMPARATOR
Intervention: Standard treatment of NASH (Ursodeoxycholic acid 15 mg/kg once a day, Atorvastatin 20 mg at night, Vitamin E 800 IU/day for 12 months)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg/day in addition to standard treatment for 12 months
Number of subjects: 51
Study: 23021631

Group type: EXPERIMENTAL
Intervention: Portable gas analysis system carried in a chest harness (PT)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control trial with the system externally supported (CT)
Number of subjects: 8
Study: 21248759

Group type: EXPERIMENTAL
Intervention: ELF‐EMF (1μT, 6- and 8 Hz, peak electric field 10 Vm(‐1), 10-15 min sessions, 2 sessions per week for 4 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham control (EMF-generating apparatus not active)
Number of subjects: 20
Study: 18276852

Group type: EXPERIMENTAL
Intervention: NK1R antagonist (LY686017)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 16982493

Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) > 1.0 mg/dl
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Immature/total neutrophil ratio (I/T) > 0.2
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Hypotension
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Mechanical ventilation
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Small-for-gestational-age (SGA) status
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Staphylococcus-specific PCR
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT)
Number of subjects: 111
Study: 12963199

Group type: EXPERIMENTAL
Intervention: OPCAB procedure (group 2)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Coronary surgery with cardiopulmonary bypass (CPB) (group 1)
Number of subjects: 176
Study: 11088095

Group type: EXPERIMENTAL
Intervention: 17‐beta estradiol with 0.5 mg of norethindrone acetate
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: 17‐beta estradiol with 0.25 mg of norethindrone acetate
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: 1 mg of 17‐beta estradiol
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: 17‐beta estradiol
Number of subjects: 270

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 270
Study: 8956574

Group type: EXPERIMENTAL
Intervention: HASTE MR cholangiography
Number of subjects: 23

Group type: COMPARATOR
Intervention: Sonography
Number of subjects: 23

Group type: COMPARATOR
Intervention: Endoscopic retrograde cholangiography
Number of subjects: 23
Study: 1541032

Group type: EXPERIMENTAL
Intervention: Regular alcohol consumption
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heavy drinking and binge drinking
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 0
Study: 30961424

Group type: EXPERIMENTAL
Intervention: Short video feedback intervention
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study: 28885089

Group type: EXPERIMENTAL
Intervention: Lifetime history of NSSI and lifetime number of suicide attempts assessed using the Columbia Suicide Severity Rating Scale (C‐SSRS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lifetime history of attempted suicide and NSSI
Number of subjects: 0
Study: 27071140

Group type: EXPERIMENTAL
Intervention: e-PRP injection
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard wound care
Number of subjects: 40
Study: 25398137

Group type: EXPERIMENTAL
Intervention: Low dose Vacc-4x
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High dose Vacc-4x
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adjuvant alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vacc-4x (all doses)
Number of subjects: 0
Study: 23872462

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (ITM) 0.1 mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Local infiltration analgesia (LIA) with ropivacaine 300 mg + ketorolac 30 mg + epinephrine 0.5 mg
Number of subjects: 80
Study: 20374662

Group type: EXPERIMENTAL
Intervention: Sports chiropractic manual therapy intervention
Number of subjects: 59

Group type: COMPARATOR
Intervention: Current best practice management (control)
Number of subjects: 59
Study: 18491137

Group type: EXPERIMENTAL
Intervention: Maximum androgen blockade (MAB) with bicalutamide (Casodex) 80 mg plus LHRHa
Number of subjects: 203

Group type: COMPARATOR
Intervention: LHRHa monotherapy
Number of subjects: 203
Study: 16785404

Group type: EXPERIMENTAL
Intervention: Microdebrider intracapsular tonsillotomy (MT)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Electrosurgical extracapsular tonsillectomy (ET)
Number of subjects: 25
Study: 12563210

Group type: EXPERIMENTAL
Intervention: Duplex ultrasound scan with ultrasound scan contrast agent
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard duplex ultrasound scan with color Doppler imaging (CDI)
Number of subjects: 20
Study: 10866885

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine
Number of subjects: 83

Group type: COMPARATOR
Intervention: Saline solution
Number of subjects: 83
Study: 9432685

Group type: EXPERIMENTAL
Intervention: Surgery for stages I and II, and in some cases for stage IIIa
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Investigational new prognostic factors (K‐ras mutations, Her2/Neu, BCL‐2 protein, p53-expression/mutation)
Number of subjects: 0
Study: 1312773

Group type: EXPERIMENTAL
Intervention: 10 mg of folic acid daily for 6 months
Number of subjects: 235

Group type: COMPARATOR
Intervention: Placebo daily for 6 months
Number of subjects: 235
Study: 2862087

Group type: EXPERIMENTAL
Intervention: Sulfonylurea
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Basal insulin supplement (ultralente insulin)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Diet alone
Number of subjects: 195
Study: 30741865

Group type: EXPERIMENTAL
Intervention: Nonperiodized (NP)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Nonlinear periodized (NLP)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Flexible nonlinear periodized (FNLP)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 54
Study: 30953549

Group type: EXPERIMENTAL
Intervention: MI/CBT intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: WHO mhGAP Intervention Guide for AUDs
Number of subjects: 40
Study: 29408866

Group type: EXPERIMENTAL
Intervention: Paracetamol only
Number of subjects: 782

Group type: EXPERIMENTAL
Intervention: Ibuprofen only
Number of subjects: 782

Group type: EXPERIMENTAL
Intervention: Combination of paracetamol and ibuprofen
Number of subjects: 782
Study: 27430870

Group type: EXPERIMENTAL
Intervention: Intra-oral camera (IOC)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control
Number of subjects: 78
Study: 24909628

Group type: EXPERIMENTAL
Intervention: Iliac crest bone grafting (n=11)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: rhBMP-2 (n=8)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (Iliac crest bone grafting)
Number of subjects: 19
Study: 23184206

Group type: EXPERIMENTAL
Intervention: Breathing retraining program (chest physiotherapy group), held once a week for three months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Subtle Touch program (paired control group)
Number of subjects: 0
Study: 20150731

Group type: EXPERIMENTAL
Intervention: 15-week physical activity programme (3 sessions per week, 1 hour each)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (no physical activities)
Number of subjects: 31
Study: 18181974

Group type: EXPERIMENTAL
Intervention: Multimarker real-time reverse transcription-PCR (RT-PCR) for quantification of melanoma markers
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: MAGE-3
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Three concordant positive markers
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Two concordant positive markers
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: One marker
Number of subjects: 65
Study: 15898930

Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CHX) 0.2% + alcohol
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CHX) 0.05% + cetyl pyridinium chloride (CPC) 0.05% without alcohol
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 45
Study: 14628599

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg once a day for 3 days
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (standard treatment with indwelling catheter and oral antibiotics)
Number of subjects: 72
Study: 10369847

Group type: EXPERIMENTAL
Intervention: Ibutilide pretreatment (1 mg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: No ibutilide pretreatment
Number of subjects: 100
Study: 7851584

Group type: EXPERIMENTAL
Intervention: Donor gametes
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Adoption
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Choice of donor source
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Known donor sources
Number of subjects: 319
Study: 1782776

Group type: EXPERIMENTAL
Intervention: Topical autologous plasma fibronectin, given 5 times per day for 11 weeks.
Number of subjects: 11

Group type: COMPARATOR
Intervention: Saline, given 5 times per day for 11 weeks (control group).
Number of subjects: 11
Study: 7026262

Group type: EXPERIMENTAL
Intervention: Methyldopa
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31580727

Group type: EXPERIMENTAL
Intervention: Mothers received pedometers
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (mothers did not receive pedometers)
Number of subjects: 50
Study: 31823753

Group type: EXPERIMENTAL
Intervention: Simple Suppers intervention
Number of subjects: 140

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 140